Company intelligence / Profile preview

KDRS

Ownership: Private
Development stage: Other

Overview

Prior to its acquisition, KDR Biotech was South Korea’s leading distributor of life science reagents, serving academic, government, and industry customers. It did not have its own clinical pipeline but played a key role in supporting research through distribution of products from global suppliers like Life Technologies[4].

Industry: Drug Discovery Services

Partnerships

Primary partnership with Life Technologies prior to acquisition; acted as their main reagent distributor in South Korea since 1982[4].

Beyond the preview

Go deeper on KDRS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KDRS.

Explore the full profile